Heron Therapeutics (HRTX) News Today $2.20 +0.05 (+2.33%) Closing price 04:00 PM EasternExtended Trading$2.24 +0.04 (+1.77%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HRTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Palisade Capital Management LP Purchases 1,360,542 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)July 3, 2025 | marketbeat.comWith 60% institutional ownership, Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst the big gunsJuly 1, 2025 | finance.yahoo.comHeron Therapeutics (NASDAQ:HRTX) Stock Crosses Above Two Hundred Day Moving Average - What's Next?July 1, 2025 | marketbeat.comCongress Park Capital LLC Has $4.48 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)June 20, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Stock Price Crosses Above 200 Day Moving Average - Here's WhyJune 19, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Heron Therapeutics (HRTX) with Buy RecommendationJune 11, 2025 | msn.comQ2 Earnings Forecast for HRTX Issued By HC WainwrightJune 11, 2025 | marketbeat.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLCJune 11, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC WainwrightJune 9, 2025 | marketbeat.comJane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)June 9, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Upgraded by Wall Street Zen to Buy RatingJune 6, 2025 | marketbeat.comNuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)June 6, 2025 | marketbeat.comTwo Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)June 4, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street ZenMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Purchases Shares of 3,075,809 Heron Therapeutics, Inc. (NASDAQ:HRTX)May 22, 2025 | marketbeat.comStonepine Capital Management LLC Invests $1.07 Million in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 20, 2025 | marketbeat.comTang Capital Management LLC Boosts Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 20, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 660,971 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)May 19, 2025 | marketbeat.comRaymond James Financial Inc. Buys Shares of 135,722 Heron Therapeutics, Inc. (NASDAQ:HRTX)May 15, 2025 | marketbeat.comJ. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX)May 14, 2025 | marketbeat.com300,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Bridgeway Capital Management LLCMay 14, 2025 | marketbeat.comQ2 Earnings Estimate for HRTX Issued By Northland CapmkMay 10, 2025 | marketbeat.comClearline Capital LP Cuts Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 10, 2025 | marketbeat.comResults: Heron Therapeutics, Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesMay 9, 2025 | finance.yahoo.comHeron Therapeutics (NASDAQ:HRTX) Releases Earnings Results, Beats Expectations By $0.03 EPSMay 8, 2025 | marketbeat.comHeron Therapeutics Target of Unusually High Options Trading (NASDAQ:HRTX)May 8, 2025 | marketbeat.comEarnings call transcript: Heron Therapeutics beats Q1 2025 expectations, stock surgesMay 7, 2025 | investing.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2025 Earnings Call TranscriptMay 7, 2025 | insidermonkey.comHeron Therapeutics Inc (HRTX) Q1 2025 Earnings Call Highlights: Record EBITDA and Significant ...May 7, 2025 | finance.yahoo.comHeron Therapeutics, Inc.: Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate UpdatesMay 6, 2025 | finanznachrichten.deHeron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call TranscriptMay 6, 2025 | seekingalpha.comHeron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate UpdatesMay 6, 2025 | prnewswire.comHeron Therapeutics Announces Settlement with Mylan Related to CINVANTI® and APONVIE® Patent LitigationsMay 6, 2025 | prnewswire.comHeron Therapeutics (HRTX) Projected to Post Quarterly Earnings on TuesdayMay 1, 2025 | marketbeat.comMarshall Wace LLP Lowers Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 1, 2025 | marketbeat.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Adage Capital Partners GP L.L.C.April 30, 2025 | marketbeat.comHeron Therapeutics, Inc.: Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating OfficerApril 30, 2025 | finanznachrichten.deHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co.April 30, 2025 | marketbeat.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Renaissance Technologies LLCApril 29, 2025 | marketbeat.comHeron Therapeutics Announces Appointment of Mark Hensley as Chief Operating OfficerApril 28, 2025 | prnewswire.comHeron Therapeutics (NASDAQ:HRTX) Stock Price Passes Above 200-Day Moving Average - Should You Sell?April 25, 2025 | marketbeat.comHeron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025April 22, 2025 | prnewswire.comQuinn Opportunity Partners LLC Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)April 14, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)April 14, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Given "Buy" Rating at Needham & Company LLCApril 13, 2025 | marketbeat.comLoss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-TermMarch 29, 2025 | finance.yahoo.comIs Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5?March 26, 2025 | insidermonkey.comRichmond Brothers Inc. Has $983,000 Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)March 20, 2025 | marketbeat.comTejara Capital Ltd Has $7.13 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)March 19, 2025 | marketbeat.comMonaco Asset Management SAM Sells 465,674 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)March 15, 2025 | marketbeat.com Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTX Media Mentions By Week HRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRTX News Sentiment▼0.980.57▲Average Medical News Sentiment HRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRTX Articles This Week▼12▲HRTX Articles Average Week Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Travere Therapeutics News Today CureVac News Today Phibro Animal Health News Today AbCellera Biologics News Today Calliditas Therapeutics AB (publ) News Today Harrow News Today WAVE Life Sciences News Today Amphastar Pharmaceuticals News Today Structure Therapeutics News Today Cogent Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRTX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
